Arena Pharmaceuticals Inc (NASDAQ:ARNA)

51.07
Delayed Data
As of Sep 20
 -0.12 / -0.23%
Today’s Change
31.97
Today|||52-Week Range
64.48
+31.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-108.0M-22.1M-90.1M-29.4M
 
 
 
 
 
Depreciation10.0M9.4M4.3M3.8M
 
 
 
 
 
Total Other Cash Flow15.1M33.5M11.0M13.9M
 
 
 
 
 
Funds From Operations-82.8M20.7M-74.8M-122.1M
 
 
 
 
 
Funds From/For Other Operating Expenses15.3M82.9M-8.2M10.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-98.1M-62.1M-66.6M-132.2M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-112.6M-364.5M
 
 
 
Decrease In Investments0.000.00--110.6M
 
 
Capital Expenditures-11.0M-950.0K-113.0K-692.0K
 
 
 
 
 
Fixed Asset Disposal2.2M954.0K789.0K0.00
 
 
 
 
Other Investing - Uses0.000.00-446.0K-11.0K
 
 
 
Other Investing - Sources609.0K0.00--3.4M
 
 
 
Net Cash Flow Investing-8.2M-750.0K-112.4M-251.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-2.5M-3.0M-3.5M-4.0M
 
 
 
 
 
Net Proceeds Stock Sale103.6M370.0K248.8M389.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.00320.0K0.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing101.1M-2.3M245.3M385.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.9M-294.0K1.9M654.0K
 
 
 
 
 
 
Net Change In Cash-5.1M-65.2M66.3M1.5M